Dr Mary M Rodocker, PHD | |
555 Middlefield Rd, Palo Alto, CA 94301 | |
(650) 321-9881 | |
(650) 493-8271 |
Full Name | Dr Mary M Rodocker |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 555 Middlefield Rd, Palo Alto, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548446750 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | PSY13278 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mary M Rodocker, PHD 555 Middlefield Rd, Palo Alto, CA 94301 Ph: (650) 321-9881 | Dr Mary M Rodocker, PHD 555 Middlefield Rd, Palo Alto, CA 94301 Ph: (650) 321-9881 |
News Archive
Wearables is very much an emerging trend and healthcare is leading this effort. Consumer technology, such as the FitBit, Jawbone, and others, are going to merge with medical devices that are already being used in hospitals today.
People with diabetes are risking their health by not discussing their use of complementary and alternative therapies with the health professionals managing their conventional treatment.
GTx, Inc. today reported financial results for the first quarter of 2010. The net income for the first quarter ended March 31, 2010 was $44.3 million compared with a net loss of $11.3 million for the same period in 2009. Net income for the current period included the recognition of approximately $54.9 million in collaboration revenue due to the termination of our license and collaboration agreement with Merck & Co., Inc in March 2010.
A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for curative treatment. In the largest analysis to date of reirradiation using intensity-modulated proton therapy for lung and other thoracic tumors, more than three-fourths of patients were free from local recurrence at one year following retreatment, and fewer than one in ten patients experienced severe side effects.
Human Genome Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the resubmission of the Biologics License Application (BLA) for raxibacumab, a treatment for inhalational anthrax, and has established December 15, 2012 as the Prescription Drug User Fee Act (PDUFA) action date.
› Verified 2 days ago
Dr. Zoi Dorit Eliou, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 665 Lytton Ave # 4, Palo Alto, CA 94301 Phone: 650-704-9424 | |
Dr. Zahra Murtaza, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 650 Clark Way, Palo Alto, CA 94304 Phone: 650-617-3829 | |
Diana Naranjo, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 401 Quarry Rd, Child And Adolescent Psychiatry, Palo Alto, CA 94304 Phone: 650-723-5511 Fax: 650-724-7389 | |
Susan Spinrad, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 560 Oxford Ave, Suite 3b, Palo Alto, CA 94306 Phone: 650-599-5825 | |
Dr. Lital Koropitzer, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 825 El Camino Real, Palo Alto, CA 94301 Phone: 650-223-6400 | |
Barbara M Sourkes, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Dr. Ferol F. Larsen, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 555 Middlefield Rd, Palo Alto, CA 94301 Phone: 650-326-6896 Fax: 650-326-6896 |